Asia-Pacific Orthobiologics Market Outlook to 2020

News provided by

Mar 20, 2014, 06:31 ET

NEW YORK, March 20, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Asia-Pacific Orthobiologics Market Outlook to 2020
http://www.reportlinker.com/p02051513/Asia-Pacific-Orthobiologics-Market-Outlook-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

Asia-Pacific Orthobiologics Market Outlook to 2020

Summary

GlobalData's new report, "Asia-Pacific Orthobiologics Market Outlook to 2020", provides key market data on the Asia-Pacific Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories – Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment–based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment–based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories – Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Orthobiologics Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Orthobiologics Market, Asia-Pacific 11

3.1 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2005-2020 11
3.2 Orthobiologics Market, Asia-Pacific, Category Comparison by Revenue ($m), 2005-2020 13
3.3 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2005-2012 15
3.4 Orthobiologics Market, Asia-Pacific, Revenue ($m), 2012-2020 17
3.5 Orthobiologics Market, Asia-Pacific, Volume (Units), 2005-2020 19
3.6 Orthobiologics Market, Asia-Pacific, Volume (Units), 2005-2012 21
3.7 Orthobiologics Market, Asia-Pacific, Volume (Units), 2012-2020 23
3.8 Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), 2011-2012 25
4 Orthobiologics Market, Australia 27
4.1 Orthobiologics Market, Australia, Revenue ($m), 2005-2012 27
4.2 Orthobiologics Market, Australia, Revenue ($m), 2012-2020 29
4.2.1 Bone Graft Substitutes Market, Australia, Revenue ($m), by Segment, 2005-2012 31
4.2.2 Bone Graft Substitutes Market, Australia, Revenue ($m), by Segment, 2012-2020 33
4.3 Orthobiologics Market, Australia, Volume (Units), 2005-2012 35
4.4 Orthobiologics Market, Australia, Volume (Units), 2012-2020 37
4.4.1 Bone Graft Substitutes Market, Australia, Volume (Units), by Segment, 2005-2012 39
4.4.2 Bone Graft Substitutes Market, Australia, Volume (Units), by Segment, 2012-2020 41
4.5 Orthobiologics Market, Australia, Average Price ($), 2005-2020 43
4.6 Orthobiologics Market, Australia, Distribution Share by Revenue ($m), 2011-2012 45
4.7 Orthobiologics Market, Australia, Company Share by Revenue ($m), 2011-2012 46
5 Orthobiologics Market, China 48

5.1 Orthobiologics Market, China, Revenue ($m), 2005-2012 48
5.2 Orthobiologics Market, China, Revenue ($m), 2012-2020 50
5.2.1 Bone Graft Substitutes Market, China, Revenue ($m), by Segment, 2005-2012 52
5.2.2 Bone Graft Substitutes Market, China, Revenue ($m), by Segment, 2012-2020 54
5.3 Orthobiologics Market, China, Volume (Units), 2005-2012 56
5.4 Orthobiologics Market, China, Volume (Units), 2012-2020 58
5.4.1 Bone Graft Substitutes Market, China, Volume (Units), by Segment, 2005-2012 60
5.4.2 Bone Graft Substitutes Market, China, Volume (Units), by Segment, 2012-2020 62
5.5 Orthobiologics Market, China, Average Price ($), 2005-2020 64
5.6 Orthobiologics Market, China, Distribution Share by Revenue ($m), 2011-2012 66
5.7 Orthobiologics Market, China, Company Share by Revenue ($m), 2011-2012 67
6 Orthobiologics Market, India 69
6.1 Orthobiologics Market, India, Revenue ($m), 2005-2012 69
6.2 Orthobiologics Market, India, Revenue ($m), 2012-2020 71
6.2.1 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2005-2012 73
6.2.2 Bone Graft Substitutes Market, India, Revenue ($m), by Segment, 2012-2020 75
6.3 Orthobiologics Market, India, Volume (Units), 2005-2012 77
6.4 Orthobiologics Market, India, Volume (Units), 2012-2020 79
6.4.1 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2005-2012 81
6.4.2 Bone Graft Substitutes Market, India, Volume (Units), by Segment, 2012-2020 83
6.5 Orthobiologics Market, India, Average Price ($), 2005-2020 85
6.6 Orthobiologics Market, India, Distribution Share by Revenue ($m), 2011-2012 87
6.7 Orthobiologics Market, India, Company Share by Revenue ($m), 2011-2012 88
7 Orthobiologics Market, Japan 90
7.1 Orthobiologics Market, Japan, Revenue ($m), 2005-2012 90
7.2 Orthobiologics Market, Japan, Revenue ($m), 2012-2020 92
7.2.1 Bone Graft Substitutes Market, Japan, Revenue ($m), by Segment, 2005-2012 94
7.2.2 Bone Graft Substitutes Market, Japan, Revenue ($m), by Segment, 2012-2020 95
7.3 Orthobiologics Market, Japan, Volume (Units), 2005-2012 96
7.4 Orthobiologics Market, Japan, Volume (Units), 2012-2020 98
7.4.1 Bone Graft Substitutes Market, Japan, Volume (Units), by Segment, 2005-2012 100
7.4.2 Bone Graft Substitutes Market, Japan, Volume (Units), by Segment, 2012-2020 101
7.5 Orthobiologics Market, Japan, Average Price ($), 2005-2020 102

7.6 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2011-2012 104
7.7 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2011-2012 105
8 Orthobiologics Market, South Korea 107
8.1 Orthobiologics Market, South Korea, Revenue ($m), 2005-2012 107
8.2 Orthobiologics Market, South Korea, Revenue ($m), 2012-2020 109
8.2.1 Bone Graft Substitutes Market, South Korea, Revenue ($m), by Segment, 2005-2012 111
8.2.2 Bone Graft Substitutes Market, South Korea, Revenue ($m), by Segment, 2012-2020 113
8.3 Orthobiologics Market, South Korea, Volume (Units), 2005-2012 115
8.4 Orthobiologics Market, South Korea, Volume (Units), 2012-2020 117
8.4.1 Bone Graft Substitutes Market, South Korea, Volume (Units), by Segment, 2005-2012 119
8.4.2 Bone Graft Substitutes Market, South Korea, Volume (Units), by Segment, 2012-2020 121
8.5 Orthobiologics Market, South Korea, Average Price ($), 2005-2020 123
8.6 Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), 2011-2012 125
8.7 Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2011-2012 126
9 Overview of Key Companies in Asia-Pacific Orthobiologics Market 128
9.1 DePuy Companies 128
9.1.1 Company Overview 128
9.2 Seikagaku Corporation 128

9.2.1 Company Overview 128
9.3 Sanofi 128
9.3.1 Company Overview 128
9.4 Medtronic, Inc. 129
9.4.1 Company Overview 129
9.5 Baxter International Inc. 129
9.5.1 Company Overview 129
9.6 Biomet, Inc. 130
9.6.1 Company Overview 130
9.7 Stryker Corporation 130
9.7.1 Company Overview 130
9.8 Smith & Nephew Plc 130
9.8.1 Company Overview 130
9.9 DJO Finance LLC 131
9.9.1 Company Overview 131
9.10 Wright Medical Group, Inc. 131
9.10.1 Company Overview 131
10 Orthobiologics Market Pipeline Products 132
11 Financial Deals Landscape 134
11.1 Asset Transactions 134
11.1.1 Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 134
11.2 Partnerships 136

11.2.1 Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 136
11.2.2 aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 137
12 Recent Developments 138
12.1 Financial Announcements 138
12.1.1 Oct 31, 2013: KYOCERA Announces Consolidated Financial Results for Six Months Ended September 30, 2013 138
12.2 Legal And Regulatory 138
12.2.1 Jan 28, 2014: 3-D Matrix Files Patent Infringement Complaint Against Menicon and B-Bridge International 138
12.2.2 Jul 05, 2013: Hanmi - Korea's First EU GMP Endorsed Injectable Powder Antibiotic 139
12.3 Strategy And Business Planning 140
12.3.1 Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation 140
13 Appendix 141
13.1 Research Methodology 142
13.1.1 Coverage 142
13.1.2 Secondary Research 142
13.1.3 Primary Research 143
13.1.4 Market Modeling and Forecasting 144
13.1.5 Company Share Analysis 147
13.1.6 Distribution Share Analysis 148
13.2 Expert Panel 148
13.3 GlobalData Consulting 149
13.4 Contact Us 149
13.5 Disclaimer 149

1.1 List of Tables

Table 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2005-2020 12
Table 2: Orthobiologics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2005-2020 14
Table 3: Orthobiologics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2005-2012 16
Table 4: Orthobiologics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2012-2020 18
Table 5: Orthobiologics Market, Asia-Pacific, Volume (Units), 2005-2020 20
Table 6: Orthobiologics Market, Asia-Pacific, Volume (Units), Historic, 2005-2012 22
Table 7: Orthobiologics Market, Asia-Pacific, Volume (Units), Forecast, 2012-2020 24
Table 8: Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2011-2012 26
Table 9: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 28
Table 10: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 30
Table 11: Bone Graft Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 32
Table 12: Bone Graft Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 34
Table 13: Orthobiologics Market, Australia, Volume (Units), Historic, 2005-2012 36

Table 14: Orthobiologics Market, Australia, Volume (Units), Forecast, 2012-2020 38
Table 15: Bone Graft Substitutes Market, Australia, Volume (Units), Historic, 2005-2012 40
Table 16: Bone Graft Substitutes Market, Australia, Volume (Units), Forecast, 2012-2020 42
Table 17: Orthobiologics Market, Australia, Average Price ($), Historic, 2005-2012 43
Table 18: Orthobiologics Market, Australia, Average Price ($), Forecast, 2012-2020 44
Table 19: Orthobiologics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 45
Table 20: Orthobiologics Market, Australia, Company Share by Revenue ($m), USD Constant, 2011-2012 47
Table 21: Orthobiologics Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 49
Table 22: Orthobiologics Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 51
Table 23: Bone Graft Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 53
Table 24: Bone Graft Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 55
Table 25: Orthobiologics Market, China, Volume (Units), Historic, 2005-2012 57
Table 26: Orthobiologics Market, China, Volume (Units), Forecast, 2012-2020 59
Table 27: Bone Graft Substitutes Market, China, Volume (Units), Historic, 2005-2012 61
Table 28: Bone Graft Substitutes Market, China, Volume (Units), Forecast, 2012-2020 63
Table 29: Orthobiologics Market, China, Average Price ($), Historic, 2005-2012 64
Table 30: Orthobiologics Market, China, Average Price ($), Forecast, 2012-2020 65
Table 31: Orthobiologics Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 66
Table 32: Orthobiologics Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 68
Table 33: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 70
Table 34: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 72
Table 35: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 74

Table 36: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 76
Table 37: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 78
Table 38: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 80
Table 39: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 82
Table 40: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 84
Table 41: Orthobiologics Market, India, Average Price ($), Historic, 2005-2012 85
Table 42: Orthobiologics Market, India, Average Price ($), Forecast, 2012-2020 86
Table 43: Orthobiologics Market, India, Distribution Share by Revenue ($m), USD Constant, 2011-2012 87
Table 44: Orthobiologics Market, India, Company Share by Revenue ($m), USD Constant, 2011-2012 89
Table 45: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2005-2012 91
Table 46: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2012-2020 93
Table 47: Bone Graft Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2005-2012 94
Table 48: Bone Graft Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2012-2020 95
Table 49: Orthobiologics Market, Japan, Volume (Units), Historic, 2005-2012 97
Table 50: Orthobiologics Market, Japan, Volume (Units), Forecast, 2012-2020 99
Table 51: Bone Graft Substitutes Market, Japan, Volume (Units), Historic, 2005-2012 100
Table 52: Bone Graft Substitutes Market, Japan, Volume (Units), Forecast, 2012-2020 101
Table 53: Orthobiologics Market, Japan, Average Price ($), Historic, 2005-2012 102
Table 54: Orthobiologics Market, Japan, Average Price ($), Forecast, 2012-2020 103
Table 55: Orthobiologics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2011-2012 104

Table 56: Orthobiologics Market, Japan, Company Share by Revenue ($m), USD Constant, 2011-2012 106
Table 57: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Historic, 2005-2012 108
Table 58: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2012-2020 110
Table 59: Bone Graft Substitutes Market, South Korea, Revenue ($m), USD Constant, Historic, 2005-2012 112
Table 60: Bone Graft Substitutes Market, South Korea, Revenue ($m), USD Constant, Forecast, 2012-2020 114
Table 61: Orthobiologics Market, South Korea, Volume (Units), Historic, 2005-2012 116
Table 62: Orthobiologics Market, South Korea, Volume (Units), Forecast, 2012-2020 118
Table 63: Bone Graft Substitutes Market, South Korea, Volume (Units), Historic, 2005-2012 120
Table 64: Bone Graft Substitutes Market, South Korea, Volume (Units), Forecast, 2012-2020 122
Table 65: Orthobiologics Market, South Korea, Average Price ($), Historic, 2005-2012 123
Table 66: Orthobiologics Market, South Korea, Average Price ($), Forecast, 2012-2020 124
Table 67: Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2011-2012 125
Table 68: Orthobiologics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2011-2012 127
Table 69: Orthobiologics Market Pipeline Products 132
Table 70: Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 134
Table 71: Artimplant Enters Into Co-Marketing Agreement With Tiller International Capital 136
Table 72: aap Implantate Enters Into Licensing Agreement With Medical Technology Company For Injectable Bone Matrix 137
Table 73: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 144

1.2 List of Figures
Figure 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2005-2020 11
Figure 2: Orthobiologics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2005-2020 13
Figure 3: Orthobiologics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2005-2012 15
Figure 4: Orthobiologics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2012-2020 17
Figure 5: Orthobiologics Market, Asia-Pacific, Volume (Units), 2005-2020 19
Figure 6: Orthobiologics Market, Asia-Pacific, Volume (Units), Historic, 2005-2012 21
Figure 7: Orthobiologics Market, Asia-Pacific, Volume (Units), Forecast, 2012-2020 23
Figure 8: Orthobiologics Market, Asia-Pacific, Company Share (%), 2012 25
Figure 9: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 27
Figure 10: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 29
Figure 11: Bone Graft Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2005-2012 31
Figure 12: Bone Graft Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2012-2020 33
Figure 13: Orthobiologics Market, Australia, Volume (Units), Historic, 2005-2012 35
Figure 14: Orthobiologics Market, Australia, Volume (Units), Forecast, 2012-2020 37
Figure 15: Bone Graft Substitutes Market, Australia, Volume (Units), Historic, 2005-2012 39
Figure 16: Bone Graft Substitutes Market, Australia, Volume (Units), Forecast, 2012-2020 41
Figure 17: Orthobiologics Market, Australia, Company Share (%), 2012 46
Figure 18: Orthobiologics Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 48
Figure 19: Orthobiologics Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 50
Figure 20: Bone Graft Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 52

Figure 21: Bone Graft Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 54
Figure 22: Orthobiologics Market, China, Volume (Units), Historic, 2005-2012 56
Figure 23: Orthobiologics Market, China, Volume (Units), Forecast, 2012-2020 58
Figure 24: Bone Graft Substitutes Market, China, Volume (Units), Historic, 2005-2012 60
Figure 25: Bone Graft Substitutes Market, China, Volume (Units), Forecast, 2012-2020 62
Figure 26: Orthobiologics Market, China, Company Share (%) 2012 67
Figure 27: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 69
Figure 28: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 71
Figure 29: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2005-2012 73
Figure 30: Bone Graft Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2012-2020 75
Figure 31: Orthobiologics Market, India, Volume (Units), Historic, 2005-2012 77
Figure 32: Orthobiologics Market, India, Volume (Units), Forecast, 2012-2020 79
Figure 33: Bone Graft Substitutes Market, India, Volume (Units), Historic, 2005-2012 81
Figure 34: Bone Graft Substitutes Market, India, Volume (Units), Forecast, 2012-2020 83
Figure 35: Orthobiologics Market, India, Company Share (%), 2012 88
Figure 36: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2005-2012 90
Figure 37: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2012-2020 92
Figure 38: Bone Graft Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2005-2012 94
Figure 39: Bone Graft Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2012-2020 95
Figure 40: Orthobiologics Market, Japan, Volume (Units), Historic, 2005-2012 96
Figure 41: Orthobiologics Market, Japan, Volume (Units), Forecast, 2012-2020 98
Figure 42: Bone Graft Substitutes Market, Japan, Volume (Units), Historic, 2005-2012 100
Figure 43: Bone Graft Substitutes Market, Japan, Volume (Units), Forecast, 2012-2020 101
Figure 44: Orthobiologics Market, Japan, Company Share (%), 2012 105

Figure 45: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Historic, 2005-2012 107
Figure 46: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2012-2020 109
Figure 47: Bone Graft Substitutes Market, South Korea, Revenue ($m), USD Constant, Historic, 2005-2012 111
Figure 48: Bone Graft Substitutes Market, South Korea, Revenue ($m), USD Constant, Forecast, 2012-2020 113
Figure 49: Orthobiologics Market, South Korea, Volume (Units), Historic, 2005-2012 115
Figure 50: Orthobiologics Market, South Korea, Volume (Units), Forecast, 2012-2020 117
Figure 51: Bone Graft Substitutes Market, South Korea, Volume (Units), Historic, 2005-2012 119
Figure 52: Bone Graft Substitutes Market, South Korea, Volume (Units), Forecast, 2012-2020 121
Figure 53: Orthobiologics Market, South Korea, Company Share (%), 2012 126
Figure 54: GlobalData Epidemiology-Based Forecasting Model 146
Figure 55: GlobalData Capital Equipment-Based Forecasting Model 147
Figure 56: Primary Interviews by Participant Type (%) 148